The findings showed that 3D-T1WI enhanced imaging omics of brain metastases from non-small cell lung cancer had high diagnostic efficacy and net clinical benefit in determining EGFR mutation status. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.